Literature DB >> 9139824

Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation.

L D Todorov1, S Mihaylova-Todorova, T D Westfall, P Sneddon, C Kennedy, R A Bjur, D P Westfall.   

Abstract

Efficient control of synaptic transmission requires a rapid mechanism for terminating the actions of neurotransmitters. For amino acids and monoamines, this is achieved by their uptake into the cell by specific high-affinity transporters; acetylcholine is first broken down in the extracellular space and then choline is taken up by the cell. Because ATP is hydrolysed to adenosine by membrane-bound enzymes (ectonucleotidases) that are present in most tissues, it has been assumed that these enzymes terminate the neurotransmitter actions of ATP in the brain and in the periphery. We show here, however, that stimulation of sympathetic nerves innervating the guinea-pig vas deferens releases not only neuronal ATP, but also soluble nucleotidases that break down this ATP to adenosine, indicating that inactivation of ATP is increased by nerve activity. This release of specific nucleotidases together with ATP represents a new mechanism for terminating the actions of a neurotransmitter.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9139824     DOI: 10.1038/387076a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  58 in total

1.  Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5'-nucleotidase along with endogenous ATP from vascular endothelial cells.

Authors:  G Yegutkin; P Bodin; G Burnstock
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

2.  Release of a soluble ATPase from the rabbit isolated vas deferens during nerve stimulation.

Authors:  T D Westfall; J R Menzies; R Liberman; S Waterston; N Ramphir; D P Westfall; P Sneddon; C Kennedy
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

3.  Regulation of the ecto-nucleotidase pathway in rat hippocampal nerve terminals.

Authors:  R A Cunha
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

4.  Extracellular metabolism of nucleotides in neuroblastoma x glioma NG108-15 cells determined by capillary electrophoresis.

Authors:  Marko Kaulich; Ramatullah Qurishi; Christa E Müller
Journal:  Cell Mol Neurobiol       Date:  2003-06       Impact factor: 5.046

5.  Physiological level of norepinephrine increases adenine nucleotides hydrolysis in rat blood serum.

Authors:  Bernardo Carraro Detanico; Joanna Ripoll Rozisky; Ana Maria Oliveira Battastini; Iraci Lucena da Silva Torres
Journal:  Purinergic Signal       Date:  2011-08-11       Impact factor: 3.765

6.  Presynaptic P2X receptors facilitate inhibitory GABAergic transmission between cultured rat spinal cord dorsal horn neurons.

Authors:  S Hugel; R Schlichter
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

7.  Extracellular metabolism of the enteric inhibitory neurotransmitter β-nicotinamide adenine dinucleotide (β-NAD) in the murine colon.

Authors:  Leonie Durnin; Masaaki Kurahashi; Kenton M Sanders; Violeta N Mutafova-Yambolieva
Journal:  J Physiol       Date:  2020-08-13       Impact factor: 5.182

8.  Rat pancreas secretes particulate ecto-nucleotidase CD39.

Authors:  Christiane E Sørensen; Jan Amstrup; Hans N Rasmussen; Ieva Ankorina-Stark; Ivana Novak
Journal:  J Physiol       Date:  2003-06-27       Impact factor: 5.182

9.  Structural insight into signal conversion and inactivation by NTPDase2 in purinergic signaling.

Authors:  Matthias Zebisch; Norbert Sträter
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

10.  An ex vivo bladder model with detrusor smooth muscle removed to analyse biologically active mediators released from the suburothelium.

Authors:  Leonie Durnin; Benjamin Kwok; Priya Kukadia; Roisin McAvera; Robert D Corrigan; Sean M Ward; Ying Zhang; Qi Chen; Sang Don Koh; Kenton M Sanders; Violeta N Mutafova-Yambolieva
Journal:  J Physiol       Date:  2018-11-02       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.